All In Biotech

Free tool

FAERS Monitor: Fensolvi Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213150 or its brand name (Fensolvi Kit, Leuprolide Acetate). Reports on generic versions are filed under their own applications.

Reports

7,739

Serious

6,129

79% of reports

Hospitalization

2,981

Death reported

1,131

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use529
  • drug ineffective448
  • fatigue393
  • hot flush292
  • fall282
  • asthenia276
  • death268
  • pneumonia249
  • prostate cancer236
  • nausea228
  • anaemia222
  • intercepted product preparation error213
  • diarrhoea203
  • diabetes mellitus194
  • prostatic specific antigen increased192

Reports by year received

View as table
YearReports
200483
200596
200685
2007119
2008351
2009153
2010237
2011236
2012301
201360
201456
2015138
2016113
2017126
2018152
2019160
2020207
2021530
2022930
2023953
2024863
2025973
2026817

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,420 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intercepted product preparation errorSignal21347.841.99,560
prostatic specific antigen increasedSignal19238.433.46,863
hot flushSignal29210.69.42,519
prostate cancerSignal2368.07.11,439
diabetes mellitusSignal1946.96.0980
anaemiaSignal2223.22.8329
fallSignal2822.32.1210
pneumoniaSignal2492.11.9143
asthenia2762.01.8138
off label use5291.61.5138
fatigue3931.41.241
drug ineffective4480.90.83
diarrhoea2030.90.75
death2680.80.88
nausea2280.80.714

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.